185 related articles for article (PubMed ID: 34593797)
21. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
[TBL] [Abstract][Full Text] [Related]
22. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1.
Yin JJ; Cheng XY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3431-3439. PubMed ID: 31081097
[TBL] [Abstract][Full Text] [Related]
24. Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research Direction.
Huang C; Zhang N; Xiong H; Wang N; Chen Z; Ni Z; Liu X; Lin B; Ge B; Du B; Huang Q
Front Immunol; 2021; 12():741634. PubMed ID: 35046932
[TBL] [Abstract][Full Text] [Related]
25. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
[TBL] [Abstract][Full Text] [Related]
26. Chromatin-Accessible miRNA Regulons Driving Thyroid Tumorigenesis and Progression.
Toraih EA; Ruiz E; Ning B; Tortelote GG; Hilliard S; Moroz K; Hu T; Fawzy MS; Kandil E
J Am Coll Surg; 2023 Apr; 236(4):732-750. PubMed ID: 36728308
[TBL] [Abstract][Full Text] [Related]
27. Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart.
Chapski DJ; Cabaj M; Morselli M; Mason RJ; Soehalim E; Ren S; Pellegrini M; Wang Y; Vondriska TM; Rosa-Garrido M
J Mol Cell Cardiol; 2021 Nov; 160():73-86. PubMed ID: 34273410
[TBL] [Abstract][Full Text] [Related]
28. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.
Beltrami CM; Dos Reis MB; Barros-Filho MC; Marchi FA; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR
Clin Epigenetics; 2017; 9():45. PubMed ID: 28469731
[TBL] [Abstract][Full Text] [Related]
29. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
30. B-cell lymphoma 2 family genes show a molecular pattern of spatiotemporal heterogeneity in gynaecologic and breast cancer.
Wang J; Li S; Lin S; Fu S; Qiu L; Ding K; Liang K; Du H
Cell Prolif; 2020 Jun; 53(6):e12826. PubMed ID: 32419250
[TBL] [Abstract][Full Text] [Related]
31. Reception of Sex Steroid Hormones in Thyroid Papillary Cancer Tissue and Relationship with Expression and Content of Transcription Factors Brn-3α and TRIM16.
Spirina LV; Chizhevskaya SY; Kondakova IV; Choinzonov EL
Bull Exp Biol Med; 2018 Dec; 166(2):237-240. PubMed ID: 30488195
[TBL] [Abstract][Full Text] [Related]
32. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
[TBL] [Abstract][Full Text] [Related]
33. RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.
Sancisi V; Manzotti G; Gugnoni M; Rossi T; Gandolfi G; Gobbi G; Torricelli F; Catellani F; Faria do Valle I; Remondini D; Castellani G; Ragazzi M; Piana S; Ciarrocchi A
Nucleic Acids Res; 2017 Nov; 45(19):11249-11267. PubMed ID: 28981843
[TBL] [Abstract][Full Text] [Related]
34. lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance.
Zhou DL; Liu Q; Xu BH; Li Y; Su X; Ye ZL; Zhang X; Peng JL; Deng L; Tang T; Shao Q; Ma JJ; Yang XH; He CY
Cancer Biomark; 2020; 29(2):255-264. PubMed ID: 32675393
[TBL] [Abstract][Full Text] [Related]
35. miR-146b measurement in FNA to distinguish papillary thyroid cancer from benign thyroid masses.
Yang F; Zhang H; Leng X; Hao F; Wang L
Br J Biomed Sci; 2018 Jan; 75(1):43-45. PubMed ID: 28937915
[No Abstract] [Full Text] [Related]
36. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
[TBL] [Abstract][Full Text] [Related]
37. Simple oligonucleotide-based multiplexing of single-cell chromatin accessibility.
Wang K; Xiao Z; Yan Y; Ye R; Hu M; Bai S; Sei E; Qiao Y; Chen H; Lim B; Lin SH; Navin NE
Mol Cell; 2021 Oct; 81(20):4319-4332.e10. PubMed ID: 34686316
[TBL] [Abstract][Full Text] [Related]
38. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
[TBL] [Abstract][Full Text] [Related]
39. Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma.
Cao W; Lee H; Wu W; Zaman A; McCorkle S; Yan M; Chen J; Xing Q; Sinnott-Armstrong N; Xu H; Sailani MR; Tang W; Cui Y; Liu J; Guan H; Lv P; Sun X; Sun L; Han P; Lou Y; Chang J; Wang J; Gao Y; Guo J; Schenk G; Shain AH; Biddle FG; Collisson E; Snyder M; Bivona TG
Nat Commun; 2020 Jul; 11(1):3675. PubMed ID: 32699215
[TBL] [Abstract][Full Text] [Related]
40. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
